Home » sfNIRS2024-Session-1 » Fr-108-Near-Infrared Spectroscopy Based Cerebral Oximetry Monitoring in Extremely Preterm Infants: Discussion of Two Recent Controversial Clinical Trials (SafeBoosC-II, SafeBoosC-III)